换一批
换一批Predictors of anti-vascular endothelial growth factor treatment responses in macular edema following central vein occlusion
摘要：
Retinal vein occlusion (RVO) ranged the second common cause of retinal vascular disease,consisting of central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO).1,2 Although the prevalence of CRVO was one-third of BRVO,it associated with worse prognosis both before and after the anti-vascular endothelial growth factor (VEGF) regimes came into clinic use.A recent pooled age-and sex-standardized analysis showed that the prevalence was 0.8 per 1 000 (CI:0.61-0.99) for CRVO around the world.3 Similarly,in our country,the 10-year incidence of CRVO in Beijing (2001-2011) was 0.3±0.1 per 100 persons.4
更多
作者单位：
Department of Ophthalmology, Shanghai First People's Hospital,School of Medicine, Shanghai JiaoTong University, Shanghai 200080, China
[1]
Shanghai Key Laboratory of Fundus Disease, Eye Research Institute of Shanghai Jiao Tong University, Shanghai 200080, China
[2]
期刊：
《中华医学杂志（英文版）》2014年127卷16期 3019-3023页
SCIMEDLINEISTICCSCDBP
栏目名称：
PERSPECTIVE
DOI：
10.3760/cma.j.issn.0366-6999.20140006
发布时间：
2014-09-11
基金项目：
This study was supported by tgrants from the National Basic Research Program of China "973 Program"
the National Natural Science Foundation of China Grant
Shanghai Key Basic Research Grant
Shanghai Scholar Leadship Grant
Shanghai Creative Key Medical Research Grant
- 翻译满意度评价：
- 提交
- 浏览：66
- 被引：6
- 下载：8
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
